Crossmark

The Saudi Arabia Food and Drug Authority: An Evaluation of the Registration Process and Good Review Practices in Saudi Arabia in Comparison with Australia, Canada and Singapore

Crossref DOI link: https://doi.org/10.1007/s40290-015-0124-4

Published Online: 2015-11-06

Published Print: 2016-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hashan, Hajed

Aljuffali, Ibrahim

Patel, Prisha

Walker, Stuart
License Information

Text and Data Mining valid from 2015-11-06

Version of Record valid from 2015-11-06
More Information

Article History

First Online: 6 November 2015

Compliance with Ethical Standards

:

: This independent research study was conducted by the Centre for Innovation in Regulatory Science, London, UK, as part of its ongoing initiatives to understand pharmaceutical development and regulatory activities in the Emerging Markets. Support for this analysis was funded in part by a grant from the Pharmaceutical Research and Manufacturers of America (PhRMA).

: Hajed Hashan is employed by the Saudi Food and Drug Authority. Ibrahim Aljuffali is Vice President of the Saudi Food and Drug Authority. Prisha Patel is employed by the Centre for Innovation in Regulatory Science, London, UK, which conducted the research described in this report. Stuart Walker is the founder of the Centre for Innovation in Regulatory Science, London, UK, which conducted the research described in this report.

Document is current

Any future updates will be listed below